Lymphatic Vessel Dynamics in the Uterine Wall

Placenta

Volumn 29, Issue SUPPL., 2008, Pages 55-59

  Red Horse, K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytotrophoblast; Endometrium; Human placentation; Lymphangiogenesis; Lymphatic vessel

Indexed keywords

VASCULOTROPIN C;

ARTICLE; CYTOTROPHOBLAST; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPH VESSEL; LYMPHANGIOGENESIS; MYOMETRIUM; PREGNANCY; PRIORITY JOURNAL; UTERUS BLOOD FLOW;

ANIMALS; FEMALE; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; PREGNANCY; UTERUS;

EID: 40849114978     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2007.11.011     Document Type: Article

References (43)

1. Benirschke K., and Kaufmann P. Pathology of the human placenta (2000), Springer-Verlag, New York
2. Oliver G. Lymphatic vasculature development. Nat Rev Immunol 4 (2004) 35-45
3. Saban M.R., Memet S., Jackson D.G., Ash J., Roig A.A., Israel A., et al. Visualization of lymphatic vessels through NF-kappaB activity. Blood 104 (2004) 3228-3230
4. Head J.R., and Lande I.J. Uterine lymphatics: passage of ink and lymphoid cells from the rat's uterine wall and lumen. Biol Reprod 28 (1983) 941-955
5. Otsuki Y., Maeda Y., Magari S., Kubo H., and Sugimoto O. Lymphatics, intraepithelial lymphocytes and endometrial lymphoid tissues in the rabbit uterus: an electron microscopic and immunohistological study. Lymphology 23 (1990) 124-134
6. Koukourakis M.I., Giatromanolaki A., Sivridis E., Simopoulos C., Gatter K.C., Harris A.L., et al. LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol 58 (2005) 202-206
7. Baluk P., Tammela T., Ator E., Lyubynska N., Achen M.G., Hicklin D.J., et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115 (2005) 247-257
8. Baluk P., Fuxe J., Hashizume H., Romano T., Lashnits E., Butz S., et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 204 (2007) 2349-2362
9. Cyster J.G. Chemokines, sphingosine-l-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 23 (2005) 127-159
10. Saeki H., Moore A.M., Brown M.J., and Hwang S.T. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 162 (1999) 2472-2475
11. Gunn M.D., Tangemann K., Tam C., Cyster J.G., Rosen S.D., and Williams L.T. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci U S A 95 (1998) 258-263
12. Rockson S.G. Lymphedema. Am J Med 110 (2001) 288-295
13. Karkkainen M.J., Ferrell R.E., Lawrence E.C., Kimak M.A., Levinson K.L., McTigue M.A., et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25 (2000) 153-159
14. Chen L., Hamrah P., Cursiefen C., Zhang Q., Pytowski B., Streilein J.W., et al. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med 10 (2004) 813-815
15. Banerji S., Ni J., Wang S.X., Clasper S., Su J., Tammi R., et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144 (1999) 789-801
16. Kaipainen A., Korhonen J., Mustonen T., van Hinsbergh V.W., Fang G.H., Dumont D., et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 92 (1995) 3566-3570
17. Wigle J.T., Harvey N., Detmar M., Lagutina I., Grosveld G., Gunn M.D., et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21 (2002) 1505-1513
18. Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5 (2004) 74-80
19. He Y., Rajantie I., Ilmonen M., Makinen T., Karkkainen M.J., Haiko P., et al. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 64 (2004) 3737-3740
20. Paavonen K., Puolakkainen P., Jussila L., Jahkola T., and Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156 (2000) 1499-1504
21. Maruyama K., Ii M., Cursiefen C., Jackson D.G., Keino H., Tomita M., et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115 (2005) 2363-2372
22. Gale N.W., Thurston G., Hackett S.F., Renard R., Wang Q., McClain J., et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev Cell 3 (2002) 411-423
23. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276 (1997) 1423-1425
24. Morisada T., Oike Y., Yamada Y., Urano T., Akao M., Kubota Y., et al. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood Jun;105 12 (2005) 4649-4656
25. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20 (2001) 672-682
26. Karpanen T., Egeblad M., Karkkainen M.J., Kubo H., Yla-Herttuala S., Jaattela M., et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61 (2001) 1786-1790
27. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7 (2001) 192-198
28. Stacker S.A., Achen M.G., Jussila L., Baldwin M.E., and Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2 (2002) 573-583
29. Red-Horse K., Rivera J., Schanz A., Zhou Y., Winn V., Kapidzic M., et al. Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation. J Clin Invest 116 (2006) 2643-2652
30. Donoghue J.F., Lederman F.L., Susil B.J., and Rogers P.A. Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum Reprod 22 (2007) 1705-1713
31. Naz R.K., and Menge A.C. Antisperm antibodies: origin, regulation, and sperm reactivity in human infertility. Fertil Steril 61 (1994) 1001-1013
32. Maroni E.S., and de Sousa M.A. The lymphoid organs during pregnancy in the mouse. A comparison between a syngeneic and an allogeneic mating. Clin Exp Immunol 13 (1973) 107-124
33. Gray H. Anatomy of the human body (2000), Lea and Febiger, Philadelphia
34. Zhou Y., McMaster M., Woo K., Janatpour M., Perry J., Karpanen T., et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160 (2002) 1405-1423
35. Zhou Y., Bellingard V., Feng K.T., McMaster M., and Fisher S.J. Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PlGF, and VEGF-C. Dev Biol 263 (2003) 114-125
36. Makinen T., Jussila L., Veikkola T., Karpanen T., Kettunen M.I., Pulkkanen K.J., et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7 (2001) 199-205
37. Sato Y., Fujiwara H., Zeng B.X., Higuchi T., Yoshioka S., and Fujii S. Platelet-derived soluble factors induce human extravillous trophoblast migration and differentiation: platelets are a possible regulator of trophoblast infiltration into maternal spiral arteries. Blood Jul;106 2 (2005) 428-435
38. Lash G.E., Schiessl B., Kirkley M., Innes B.A., Cooper A., Searle R.F., et al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol 80 (2006) 572-580
39. Li X.F., Charnock-Jones D.S., Zhang E., Hiby S., Malik S., Day K., et al. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab 86 (2001) 1823-1834
40. Hanna J., Goldman-Wohl D., Hamani Y., Avraham I., Greenfield C., Natanson-Yaron S., et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 12 (2006) 1065-1074
41. Lamont R.F. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth. BJOG 110 Suppl. 20 (2003) 71-75
42. Fehniger T.A., Cooper M.A., Nuovo G.J., Cella M., Facchetti F., Colonna M., et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101 (2003) 3052-3057
43. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97 (2001) 3146-3151